Haemonetics | HAE - Ordinary Share Capital


Haemonetics reported $46.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Globus Medical USD 135.67M 611K Mar/2026
Haemonetics USD 46.83M 82K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Intuitive Surgical USD 354.16M 1.01M Jun/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.71M 55K Jun/2026
Neogen USD 217.7M 27K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 275K 138.4M Mar/2026
Quidel USD 68.1M 200K Mar/2026
ResMed USD 190.83M 44.86M Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 383.4M 416K Jun/2026
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
US Physical Therapy USD 15.23M 107.81K Mar/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026